Velcade 3.5 mg Injection
  1. Home
  2. Pharma Products
  3. Johnson & Johnson Pvt Ltd
  4. Velcade 3.5 mg Injection

Velcade 3.5 mg Injection

Velcade 3.5 mg Injection contains bortezomib 3.5 mg, a proteasome inhibitor used as an anticancer medicine. It is mainly used in the treatment of multiple myeloma and mantle-cell lymphoma. The injection is administered by a qualified healthcare professional through intravenous or subcutaneous administration.

BUY NOW

Category

Bortezomib blocks proteasomes inside cells, disrupting the breakdown of proteins and promoting the death of certain cancer cells. It may be used alone or with other anticancer medicines according to the prescribed treatment protocol. Regular monitoring of blood counts and other clinical parameters is important because treatment can cause low blood-cell counts, peripheral neuropathy, gastrointestinal effects, and other adverse reactions. The dose and treatment schedule are individualized by the treating oncologist according to the disease and treatment response.

Technical Specification

Specification Details
Active Ingredient Bortezomib
Strength 3.5 mg
Dosage Form Lyophilized Powder for Injection
Route of Administration Intravenous or Subcutaneous
Pack Size 1 Vial
Manufacturer / Marketer Janssen Pharmaceuticals

Product Also Known As

Velcade 3.5mg Injection, Velcade 3.5 mg Injection, Velcade 3.5mg Vial, Bortezomib 3.5mg Injection, Bortezomib 3.5 mg Injection, Bortezomib 3.5mg Vial, Bortezomib Anticancer Injection

Related products